Annual Debt To Equity
0.27
+0.27+100.00%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual debt to equity ratio is 0.27, with the most recent change of +0.27 (+100.00%) on December 1, 2023.
- During the last 3 years, RNAZ annual debt to equity has risen by +0.88 (+144.26%).
- RNAZ annual debt to equity is now at all-time high.
Performance
RNAZ Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.09
-0.08-47.06%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly debt to equity ratio is 0.09, with the most recent change of -0.08 (-47.06%) on September 1, 2024.
- Over the past year, RNAZ quarterly debt to equity has dropped by -0.04 (-30.77%).
- RNAZ quarterly debt to equity is now -71.88% below its all-time high of 0.32, reached on June 30, 2023.
Performance
RNAZ Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
RNAZ Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -30.8% |
| 3 y3 years | +144.3% | +100.0% |
| 5 y5 years | +132.1% | - |
RNAZ Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -71.9% | +102.8% |
| 5 y | 5-year | at high | +132.1% | -71.9% | +102.8% |
| alltime | all time | at high | +132.1% | -71.9% | +102.8% |
TransCode Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.09(-47.1%) |
| Jun 2024 | - | 0.17(+142.9%) |
| Mar 2024 | - | 0.07(-74.1%) |
| Dec 2023 | 0.27(>+9900.0%) | 0.27(+107.7%) |
| Sep 2023 | - | 0.13(-59.4%) |
| Jun 2023 | - | 0.32(-109.9%) |
| Mar 2023 | - | -3.24(<-9900.0%) |
| Dec 2022 | 0.00 | 0.00(0.0%) |
| Sep 2022 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 0.00(0.0%) |
| Mar 2022 | - | 0.00(0.0%) |
| Dec 2021 | 0.00(-100.0%) | 0.00(0.0%) |
| Sep 2021 | - | 0.00(-100.0%) |
| Jun 2021 | - | -0.42(+55.6%) |
| Mar 2021 | - | -0.27(-55.7%) |
| Dec 2020 | -0.61(-27.4%) | - |
| Dec 2020 | - | -0.61 |
| Dec 2019 | -0.84 | - |
FAQ
- What is TransCode Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for TransCode Therapeutics?
- What is TransCode Therapeutics annual debt to equity year-on-year change?
- What is TransCode Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly debt to equity year-on-year change?
What is TransCode Therapeutics annual debt to equity ratio?
The current annual debt to equity of RNAZ is 0.27
What is the all time high annual debt to equity for TransCode Therapeutics?
TransCode Therapeutics all-time high annual debt to equity ratio is 0.27
What is TransCode Therapeutics annual debt to equity year-on-year change?
Over the past year, RNAZ annual debt to equity ratio has changed by +0.27 (+100.00%)
What is TransCode Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of RNAZ is 0.09
What is the all time high quarterly debt to equity for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly debt to equity ratio is 0.32
What is TransCode Therapeutics quarterly debt to equity year-on-year change?
Over the past year, RNAZ quarterly debt to equity ratio has changed by -0.04 (-30.77%)